Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Report by Yichen Dong, MD, Long Xu, MD, Jialiang Wen, MD, Haojie Si, MD, Juemin Yu, MD, Tao Chen, MD, Huikang Xie, MD, Xinjian Li, MD, Minglei Yang, MD, Junqiang Fan, MD, Junqi Wu, MD, Yunlang She, MD, Deping Zhao, MD, Chang Chen, MD, PhD

Subjects: Get full text

Case report: Watch-and-wait strategy in resectable esophageal cancer following neoadjuvant chemoimmunotherapy: a case series by Lingyu Tan, Lingyu Tan, Guozhen Yang, Guozhen Yang, Chufeng Zeng, Chufeng Zeng, Xu Zhang, Xu Zhang, Xu Zhang

Subjects: “…neoadjuvant chemoimmunotherapy…”
Get full text

Right versus left thoracic approach esophagectomy for patients with neoadjuvant immunochemotherapy by Kexi Wang, Xuan Xie, Jianqun He, Shuogui Fang, Yiming Zhong, Duoguang Wu, Kefeng Wang, Minghui Wang

Subjects: “…Neoadjuvant chemoimmunotherapy…”
Get full text